Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference74 articles.
1. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis;X Zhu;Am J Kidney Dis,2007
2. Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials;Feng Hang Xiao;Eur J Clin Pharmacol,2011
3. Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials;S Geiger-Gritsch;The Oncologist,2010
4. Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature;Yuan Su;PLoS ONE,2012
5. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement;D Moher;Int J Surg,2010
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Systemic bevacizumab for treatment of recurrent respiratory papillomatosis;European Archives of Oto-Rhino-Laryngology;2024-01-05
2. Bevacizumab side effects and adverse clinical complications in colorectal cancer patients: review article;Annals of Medicine & Surgery;2023-06-26
3. l-carvone decreases breast cancer cells adhesion, migration, and invasion by suppressing FAK activation;Chemico-Biological Interactions;2023-06
4. Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study;Clinical and Experimental Medicine;2023-02-04
5. Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review;World Journal of Gastrointestinal Endoscopy;2022-07-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3